85.76

0.66% 0.56

After Hours: 85.76

Iradimed Corp (IRMD)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Iradimed Corp stock is traded at $85.76, with a volume of 92,626. It is up +0.66% in the last 24 hours and down -2.40% over the past month. iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

Previous Close:

$85.20

Open:

$85.2

24h Volume:

92,626

Relative Volume:

0.75

Market Cap:

$1.10B

Revenue:

$86.28M

Net Income/Loss:

$23.61M

P/E Ratio:

46.71

EPS:

1.8359

Net Cash Flow:

$23.97M

1W Performance:

+4.43%

1M Performance:

-2.40%

6M Performance:

-15.74%

1Y Performance:

+25.11%

1-Day Range:

$84.77

$86.24

1-Week Range:

$81.51

$87.91

52-Week Range:

$67.84

$107.90

Iradimed Corp Stock (IRMD) Company Profile

Name

Iradimed Corp

Sector

Healthcare (1067)

Industry

Medical Devices (139)

Phone

(407) 677-8022

Address

12705 INGENUITY DRIVE, ORLANDO

Employee

166

Twitter

Next Earnings Date

2026-11-02

Latest SEC Filings

IRMD's Discussions on Twitter

Compare IRMD vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRMD Iradimed Corp	85.76	1.10B	86.28M	23.61M	23.97M	1.8359
ABT Abbott Laboratories	101.29	175.27B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	88.64	113.38B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	272.36	104.47B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.92	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.29	49.74B	6.30B	1.07B	1.09B	1.8406

Iradimed Corp Stock (IRMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-12-23	Initiated	Lake Street	Buy
Oct-31-17	Resumed	ROTH Capital	Buy
Oct-05-16	Downgrade	ROTH Capital	Buy → Neutral
Nov-02-15	Reiterated	ROTH Capital	Buy
Jul-30-15	Reiterated	ROTH Capital	Buy
Jun-16-15	Reiterated	ROTH Capital	Buy
Jan-12-15	Reiterated	ROTH Capital	Buy
Dec-23-14	Reiterated	ROTH Capital	Buy

View All

Iradimed Corp Stock (IRMD) Latest News

Sep 25, 2026

IRadimed Director Joe Kiani Acquires 698 Shares Through RSU Vesting on September 23, 2026 - Kalkine Media

Sep 25, 2026

Form 4 Iradimed Co For: 25 September By Investing.com - Investing.com Canada

Sep 25, 2026

698 stock units became shares for IRADIMED (NASDAQ: IRMD) director Joe E. Kiani. - Stock Titan

Sep 25, 2026

Sep 23, 2026

One-on-one investor meetings with Iradimed's CFO are set for New York - Stock Titan

Sep 23, 2026

Sep 22, 2026

Needham initiates IRadimed stock with Hold on valuation concerns By Investing.com - Investing.com Nigeria

Sep 22, 2026

Needham initiates IRadimed stock with Hold on valuation concerns - Investing.com

Sep 22, 2026

iRadimed initiated with a Hold at Needham - TipRanks

Sep 22, 2026

Needham Initiates IRadimed at Hold - marketscreener.com

Sep 22, 2026

Sep 09, 2026

Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com Australia

Sep 09, 2026

Sep 08, 2026

Iradimed director Monty Allen sells $122,621 in stock - Investing.com

Sep 08, 2026

Director at IRADIMED (IRMD) sells 1,419 shares - Stock Titan

Sep 08, 2026

Sep 04, 2026